Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NPCE

NeuroPace Inc

Sep 13 • 04:00PM ET

7.43

Dollar change +0.20
Percentage change 2.77	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VTWO IWC VTWG RSSL VTHR URTY

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.09	Insider Own	50.62%	Shs Outstand	27.82M	Perf Week	3.19%
Market Cap	216.96M	Forward P/E	-	EPS next Y	-0.86	Insider Trans	-3.89%	Shs Float	14.42M	Perf Month	9.75%
Income	-29.90M	PEG	-	EPS next Q	-0.27	Inst Own	37.76%	Short Float	3.59%	Perf Quarter	11.23%
Sales	71.82M	P/S	3.02	EPS this Y	13.84%	Inst Trans	-1.23%	Short Ratio	5.41	Perf Half Y	-45.49%
Book/sh	0.34	P/B	21.90	EPS next Y	21.41%	ROA	-30.41%	Short Interest	0.52M	Perf Year	-10.59%
Cash/sh	1.90	P/C	3.91	EPS next 5Y	-	ROE	-192.19%	52W Range	5.75 - 18.15	Perf YTD	-27.93%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-0.33%	ROI	-36.55%	52W High	-59.06%	Beta	1.82
Dividend TTM	-	Quick Ratio	5.47	Sales past 5Y	16.39%	Gross Margin	74.15%	52W Low	29.22%	ATR (14)	0.59
Dividend Ex-Date	-	Current Ratio	6.37	EPS Y/Y TTM	35.99%	Oper. Margin	-34.50%	RSI (14)	51.50	Volatility	6.32% 8.43%
Employees	171	Debt/Eq	7.46	Sales Y/Y TTM	30.75%	Profit Margin	-41.63%	Recom	1.29	Target Price	14.57
Option/Short	Yes / Yes	LT Debt/Eq	7.28	EPS Q/Q	27.30%	Payout	-	Rel Volume	0.43	Prev Close	7.23
Sales Surprise	5.24%	EPS Surprise	13.33%	Sales Q/Q	16.63%	Earnings	Aug 13 AMC	Avg Volume	95.63K	Price	7.43
SMA20	0.68%	SMA50	0.64%	SMA200	-29.36%	Trades		Volume	40,703	Change	2.77%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-14-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$16 → $20
Jan-30-24	Initiated	Leerink Partners	Outperform	$22
Nov-10-23	Initiated	Cantor Fitzgerald	Overweight	$11
Aug-24-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$5 → $6
Feb-22-23	Initiated	Lake Street	Buy	$10
Apr-06-22	Initiated	Wolfe Research	Outperform	$13
Jan-19-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$11
Jan-07-22	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$17 → $12
Nov-11-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-18-21	Initiated	Robert W. Baird	Outperform	$26
May-17-21	Initiated	Wells Fargo	Overweight	$25
May-17-21	Initiated	SVB Leerink	Outperform	$25
May-17-21	Initiated	Morgan Stanley	Overweight	$26
May-17-21	Initiated	JP Morgan	Overweight	$27

Show Previous Ratings

Sep-04-24 04:05PM	NeuroPace Strengthens Management Team with Two Key Appointments (GlobeNewswire)
Aug-27-24 04:05PM	NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences (GlobeNewswire)
Aug-22-24 04:05PM	NeuroPace to Participate in Upcoming Healthcare Conferences in September (GlobeNewswire) -5.65% +12.98%
Aug-20-24 07:37AM	NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up (Zacks)
Aug-13-24 04:05PM	NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (GlobeNewswire) +5.51% -7.01%
04:05PM	Loading…
Jul-23-24 04:05PM	NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024 (GlobeNewswire) +10.59%
May-14-24 04:05PM	NeuroPace to Participate in Two Healthcare Conferences in May (GlobeNewswire) +6.11%
May-13-24 10:46AM	NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript (Insider Monkey)
06:53AM	Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating (MT Newswires)
May-10-24 03:38PM	NeuroPace Inc (NPCE) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Ongoing Challenges (GuruFocus.com) +6.65%
May-09-24 03:47AM	NeuroPace Inc (NPCE) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ... (GuruFocus.com) -36.75%
May-08-24 04:05PM	NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -5.26%
Apr-17-24 04:05PM	NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024 (GlobeNewswire)
Apr-04-24 12:20PM	Time to Hit Buy, Says Wells Fargo About These 2 Stocks (TipRanks)
Mar-27-24 04:05PM	NeuroPace to Present at the Needham 23rd Annual Healthcare Conference (GlobeNewswire)
11:44AM	Loading…
Mar-07-24 11:44AM	NeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 06:28AM	Q4 2023 Neuropace Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-05-24 09:52PM	NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:05PM	NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million (GlobeNewswire)
02:00PM	Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio (InvestorPlace)
Feb-23-24 05:15AM	20 Most Valuable Digital Health Companies In The US (Insider Monkey) +11.17%
Feb-15-24 04:05PM	NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 (GlobeNewswire)
Feb-07-24 03:13AM	NeuroPace Inc Chief Medical Officer Martha Morrell Sells 17,589 Shares (GuruFocus.com) +5.80%
Feb-01-24 11:02PM	NeuroPace Inc Chief Medical Officer Martha Morrell Sells 13,848 Shares (GuruFocus.com)
Jan-08-24 07:03AM	NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates (GlobeNewswire) +12.89%
Dec-29-23 09:01PM	NeuroPace Inc Chief Medical Officer Martha Morrell Sells 13,402 Shares (GuruFocus.com) -5.14%
Dec-21-23 07:07AM	NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study (GlobeNewswire)
Dec-19-23 04:30PM	NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +6.68% -6.36%
Dec-04-23 05:07PM	NeuroPace to Leverage the Power of its RNS System's Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration (GlobeNewswire) -8.65%
Dec-01-23 08:00AM	NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting (GlobeNewswire)
08:00AM	Loading…
Nov-21-23 08:00AM	NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-07-23 09:45AM	NeuroPace, Inc. (NASDAQ:NPCE) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-06-23 04:33PM	NeuroPace Inc (NPCE) Reports 47% YoY Revenue Growth in Q3 2023, Raises Full Year Revenue Guidance (GuruFocus.com)
04:03PM	NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance (GlobeNewswire)
Oct-26-23 10:33AM	12 Best Performing NASDAQ Stocks in 2023 (Insider Monkey)
Oct-17-23 04:05PM	NeuroPace Announces RNS System Enhancements Designed to Streamline Care (GlobeNewswire)
Oct-16-23 05:01PM	NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023 (GlobeNewswire)
Oct-05-23 01:02AM	OrbiMed Advisors LLC Reduces Stake in NeuroPace Inc (GuruFocus.com)
Sep-29-23 03:16PM	20 Countries With Highest Rate of Epilepsy (Insider Monkey)
Sep-20-23 04:05PM	NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire) -5.39%
Aug-24-23 04:05PM	NeuroPace to Participate in Upcoming Investor Conferences (GlobeNewswire) +7.95% +16.28%
Aug-13-23 08:03AM	Rainbows and Unicorns: NeuroPace, Inc. (NASDAQ:NPCE) Analysts Just Became A Lot More Optimistic (Simply Wall St.)
Aug-08-23 04:03PM	NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance (GlobeNewswire) +9.76%
Jul-19-23 04:03PM	NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market (GlobeNewswire)
Jul-18-23 04:05PM	NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023 (GlobeNewswire)
Jun-28-23 04:03PM	NeuroPace Announces CEO Transition (GlobeNewswire)
May-24-23 04:05PM	NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales (GlobeNewswire)
May-05-23 10:13AM	Q1 2023 Neuropace Inc Earnings Call (Thomson Reuters StreetEvents)
May-04-23 04:05PM	NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance (GlobeNewswire)
Apr-17-23 04:05PM	NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023 (GlobeNewswire)
06:39AM	Further Upside For NeuroPace, Inc. (NASDAQ:NPCE) Shares Could Introduce Price Risks After 39% Bounce (Simply Wall St.)
Apr-03-23 04:05PM	NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire) -5.15%
Mar-30-23 07:32AM	NeuroPace (NASDAQ:NPCE) adds US$17m to market cap in the past 7 days, though investors from a year ago are still down 44% (Simply Wall St.) +6.96%
Mar-06-23 05:52AM	NeuroPace, Inc. (NASDAQ:NPCE) Q4 2022 Earnings Call Transcript (Insider Monkey) +12.20%
Mar-03-23 06:07AM	Q4 2022 Neuropace Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-02-23 04:05PM	NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results (GlobeNewswire) -11.21%
Feb-10-23 08:00AM	NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023 (GlobeNewswire)
Jan-09-23 04:03PM	NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors (GlobeNewswire) +35.58%
Dec-21-22 04:03PM	NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-30-22 08:00AM	NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway (Business Wire)
Nov-11-22 05:25AM	NeuroPace Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-08-22 04:03PM	NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update (GlobeNewswire) +8.58% -16.99%
Nov-04-22 04:03PM	NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference (GlobeNewswire)
Oct-25-22 04:03PM	NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022 (GlobeNewswire) -9.68%
Oct-21-22 06:44AM	Shareholders in NeuroPace (NASDAQ:NPCE) are in the red if they invested a year ago (Simply Wall St.) -7.36%
Oct-11-22 08:00AM	NeuroPace Announces First Patient Implanted in NAUTILUS Pivotal Study for the Treatment of Idiopathic Generalized Epilepsy (IGE) (Business Wire)
Aug-23-22 04:06PM	NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference (GlobeNewswire)
Aug-12-22 02:31AM	NeuroPace, Inc. (NPCE) Q2 2022 Earnings Call Transcript (Motley Fool) -6.96%
Aug-11-22 04:02PM	NeuroPace Reports Second Quarter 2022 Financial Results and Provides a Business Update (GlobeNewswire)
04:02PM	NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery (GlobeNewswire)
Jul-21-22 04:03PM	NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022 (GlobeNewswire)
May-13-22 03:38PM	Shareholders in NeuroPace (NASDAQ:NPCE) are in the red if they invested a year ago (Simply Wall St.)
08:00AM	NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
04:30AM	NeuroPace, Inc. (NPCE) Q1 2022 Earnings Call Transcript (Motley Fool)
May-12-22 04:03PM	NeuroPace Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-04-22 08:00AM	NeuroPace Announces First Patient Treated in Pivotal Study Evaluating the RNS System in Adolescents (Business Wire)
Apr-21-22 04:03PM	NeuroPace to Report First Quarter 2022 Financial Results on May 12, 2022 (GlobeNewswire)
Mar-21-22 07:49AM	Meridian Bioscience and NeuroPace have been highlighted as Zacks Bull and Bear of the Day (Zacks)
06:20AM	Bear of the Day: NeuroPace (NPCE) (Zacks)
Mar-10-22 08:00PM	NeuroPace, Inc. (NPCE) Q4 2021 Earnings Call Transcript (Motley Fool) -6.63% +6.18%
04:02PM	NeuroPace Reports Fourth Quarter & Full Year 2021 Financial Results (GlobeNewswire)
Jan-27-22 04:03PM	NeuroPace to Report Fourth Quarter and Full Year 2021 Financial Results and Present at the 11th Annual SVB Leerink Global Healthcare Conference (GlobeNewswire) -5.62%
Jan-11-22 04:03PM	NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue (GlobeNewswire) +6.67% +7.19%
Dec-16-21 07:00AM	NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-11-21 10:00AM	NeuroPace, Inc. (NPCE) Q3 2021 Earnings Call Transcript (Motley Fool) -11.39%
Nov-10-21 04:03PM	NeuroPace Reports Third Quarter 2021 Financial Results (GlobeNewswire)
04:02PM	NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy (GlobeNewswire)
Oct-20-21 04:05PM	NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021 (GlobeNewswire)
Oct-19-21 04:03PM	NeuroPace Announces Addition of Lisa Andrade to the Board (GlobeNewswire)
Sep-20-21 09:34AM	Calculating The Fair Value Of NeuroPace, Inc. (NASDAQ:NPCE) (Simply Wall St.) -5.91%
Aug-23-21 04:03PM	NeuroPace to Participate in Upcoming Conferences (GlobeNewswire)
Aug-13-21 08:30AM	NeuroPace, Inc. (NPCE) Q2 2021 Earnings Call Transcript (Motley Fool) -5.12%
Aug-12-21 04:03PM	NeuroPace Reports Second Quarter 2021 Financial Results (GlobeNewswire)
Aug-04-21 08:00AM	NeuroPace Launches nSight Platform and Partnership with Seizure Tracker to Provide Doctors With Personalized Information About Their Patients Seizure Burden (Business Wire)
Jul-22-21 04:03PM	NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021 (GlobeNewswire)
05:37AM	Have Insiders Been Buying NeuroPace, Inc. (NASDAQ:NPCE) Shares? (Simply Wall St.)
Jul-03-21 07:07AM	Could This Recently IPOed Medical Device Maker Make You Rich? (Motley Fool)
Jun-30-21 08:00AM	NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Syndrome (GlobeNewswire)
Jun-03-21 07:00AM	NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance (GlobeNewswire)
06:45AM	NeuroPace Inc to Host Earnings Call (ACCESSWIRE)

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ORBIMED ADVISORS LLC	10% Owner	May 01 '24	Sale	14.02	15,690	219,974	3,419,851	May 03 05:16 PM
ORBIMED ADVISORS LLC	10% Owner	May 02 '24	Sale	14.01	8,842	123,876	3,411,009	May 03 05:16 PM
ORBIMED ADVISORS LLC	10% Owner	May 03 '24	Sale	14.03	4,674	65,576	3,406,335	May 03 05:16 PM
ORBIMED ADVISORS LLC	10% Owner	Apr 24 '24	Sale	14.06	1,781	25,041	3,435,541	Apr 26 05:01 PM
ORBIMED ADVISORS LLC	10% Owner	Apr 22 '24	Sale	14.05	24,609	345,756	3,459,113	Apr 23 06:38 PM
ORBIMED ADVISORS LLC	10% Owner	Apr 23 '24	Sale	14.29	21,791	311,393	3,437,322	Apr 23 06:38 PM
ORBIMED ADVISORS LLC	10% Owner	Apr 19 '24	Sale	14.02	18,253	255,907	3,483,722	Apr 23 06:38 PM
ORBIMED ADVISORS LLC	10% Owner	Apr 16 '24	Sale	14.01	14,069	197,107	3,504,898	Apr 18 05:10 PM
ORBIMED ADVISORS LLC	10% Owner	Apr 18 '24	Sale	14.06	2,623	36,879	3,501,975	Apr 18 05:10 PM
ORBIMED ADVISORS LLC	10% Owner	Apr 17 '24	Sale	14.15	300	4,245	3,504,598	Apr 18 05:10 PM
ORBIMED ADVISORS LLC	10% Owner	Apr 11 '24	Sale	14.49	461,899	6,692,917	3,542,068	Apr 15 05:25 PM
ORBIMED ADVISORS LLC	10% Owner	Apr 12 '24	Sale	14.42	23,101	333,116	3,518,967	Apr 15 05:25 PM
Morrell Martha	Chief Medical Officer	Feb 02 '24	Sale	15.07	14,143	213,122	81,208	Feb 06 07:16 PM
Morrell Martha	Chief Medical Officer	Feb 05 '24	Sale	15.17	3,446	52,278	77,762	Feb 06 07:16 PM
Morrell Martha	Chief Medical Officer	Jan 30 '24	Sale	15.10	11,262	170,004	97,937	Feb 01 09:47 PM
Morrell Martha	Chief Medical Officer	Jan 31 '24	Sale	15.08	1,923	28,990	96,014	Feb 01 09:47 PM
Morrell Martha	Chief Medical Officer	Feb 01 '24	Sale	15.04	663	9,971	95,351	Feb 01 09:47 PM
Morrell Martha	Chief Medical Officer	Jan 24 '24	Sale	15.03	827	12,426	109,200	Jan 26 06:04 PM
Morrell Martha	Chief Medical Officer	Jan 25 '24	Sale	15.00	1	15	109,199	Jan 26 06:04 PM
Morrell Martha	Chief Medical Officer	Dec 27 '23	Sale	10.12	13,300	134,648	110,027	Dec 28 05:47 PM
Morrell Martha	Chief Medical Officer	Dec 26 '23	Sale	10.00	102	1,020	123,327	Dec 28 05:47 PM
Morrell Martha	Chief Medical Officer	Dec 20 '23	Sale	10.14	2,730	27,695	123,429	Dec 22 04:21 PM
Morrell Martha	Chief Medical Officer	Dec 06 '23	Sale	8.16	11,005	89,773	126,159	Dec 07 04:07 PM
KCK LTD.	10% Owner	Nov 30 '23	Sale	8.84	7,282	64,373	5,597,014	Dec 01 09:57 PM
KCK LTD.	10% Owner	Nov 29 '23	Sale	8.72	5,644	49,216	5,604,296	Dec 01 09:57 PM
KCK LTD.	10% Owner	Dec 01 '23	Sale	8.73	3,241	28,294	5,593,773	Dec 01 09:57 PM
KCK LTD.	10% Owner	Nov 27 '23	Sale	8.96	6,490	58,150	5,614,621	Nov 29 05:35 PM
KCK LTD.	10% Owner	Nov 28 '23	Sale	8.75	4,681	40,959	5,609,940	Nov 29 05:35 PM
ORBIMED ADVISORS LLC	10% Owner	Oct 02 '23	Sale	9.08	7,614	69,135	4,004,667	Oct 04 05:36 PM
ORBIMED ADVISORS LLC	10% Owner	Oct 03 '23	Sale	9.02	700	6,314	4,003,967	Oct 04 05:36 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NPCE

NeuroPace Inc

Upgrade your FINVIZ experience